EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 85 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,629 | -29.3% | 117,100 | -23.0% | 0.02% | -28.1% |
| Q2 2023 | $1,323,270 | +1400.3% | 152,100 | +407.0% | 0.03% | +1500.0% |
| Q1 2023 | $88,200 | -56.8% | 30,000 | +15.8% | 0.00% | -60.0% |
| Q2 2022 | $204,000 | -72.2% | 25,900 | -57.1% | 0.01% | -64.3% |
| Q1 2022 | $734,000 | -33.6% | 60,400 | -33.1% | 0.01% | -33.3% |
| Q4 2021 | $1,105,000 | -6.0% | 90,300 | -20.0% | 0.02% | -4.5% |
| Q3 2021 | $1,176,000 | +0.8% | 112,820 | -13.1% | 0.02% | +4.8% |
| Q2 2021 | $1,167,000 | +2.3% | 129,820 | +15.6% | 0.02% | 0.0% |
| Q1 2021 | $1,141,000 | +221.4% | 112,319 | +108.3% | 0.02% | +162.5% |
| Q4 2020 | $355,000 | – | 53,919 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |